Clinical Trials Directory

Trials / Completed

CompletedNCT02809378

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of Postoperative Nausea and Vomiting in the Women Patients Undergoing Thyroidectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The incidence of postoperative nausea and vomiting (PONV) after thyroidectomy have been shown to be relatively high compared other surgeries, with a reported incidence 65-75 %. PONV may increase patient discomfort, delay patient discharge, and increase the cost of patient care, the risk of postoperative bleeding which may potentially cause airway obstruction. It is reported that the maintenance of anesthesia with propofol-remifentanil or sevoflurane-propofol-remifentanil decreased the incidence of PONV compared sevoflurane alone, but failed to demonstrate the decreased incidence of PONV in 6-24 hr postoperative period in patients undergoing thyroidectomy. Administration of Palonosetron, newly developed 5-HT3 antagonists with long half life (48 hrs) may decrease the incidence of PONV particularly during this period. The purpose of this study was to evaluate and compare the incidence of PONV after thyroidectomy with three different anesthetic methods, sevoflurane or sevoflurane-propofol-remifentanil or sevoflurane-propofol-remifentanil-palonosetron in woman patients.

Conditions

Interventions

TypeNameDescription
DRUGPalonosetronnewly developed 5-HT3 antagonists with long half life (48 hrs) intravenous administration prior to anesthesia induction
DRUGsevofluraneInhalational anesthetics Halogenated.
DRUGremifentanilultra-short acting opioid anesthetics
DRUGpentothal sodiumintra-venous anesthetics for anesthesia induction
DRUGpropofolintra-venous anesthetics for anesthesia induction and maintenance

Timeline

Start date
2016-06-01
Primary completion
2017-04-20
Completion
2017-04-20
First posted
2016-06-22
Last updated
2017-07-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02809378. Inclusion in this directory is not an endorsement.